Quick Facts of the Week:
This week, there were 2 investment and financing cases in the domestic digital health industry, including medical AI, medical ** marketing, etc.
Corporate Events:
1 The Shanghai Biomedical Digital Operation Standard Innovation Consortium was established in Shanghai.
2 Sir Run Run Shaw Hospital of Zhejiang University introduced AI doctor assistants to improve the efficiency of medical treatment.
Technological innovation:
1 Zhiyu Medical waterjet surgical robot completed the first clinical trial operation of waterjet robot in China.
2 Studying wireless drug patches is expected to provide a solution for chronic diseases**.
oneFinancing mergers and acquisitions
1 Medical artificial intelligence: Huimei Technology received an investment of 70 million yuan from Newerly Capital, with a total of 3700 million yuan
Recently, Nuerley Capital delivered an investment of 70 million yuan to Huimei Technology, and the cumulative financing amount of Huimei Technology's D round reached 3700 million RMB. In September 2023, Huimei Technology has completed the main part of the D round of financing, with a financing of more than 300 million yuan led by Bell Capital, followed by Runzhang Venture Capital, Suzhou Yihe, Qiming Venture Capital and other well-known investment institutions. Founded in 2015, Beijing Huimeiyun Technology has always focused on the in-depth mining of medical big data, as well as the research and development and clinical application of medical artificial intelligence products. The company has established an AI product system in line with China's medical model, covering the whole process of clinical business, and its core functions meet the needs of different levels and multi-dimensional applications.
arterial net).2 Medical** Marketing: Haoxi Health Technology*** announced IPO pricing
On January 25, Hysea Health Technology, a marketing solutions provider headquartered in Beijing, China, today announced its initial public offering (the "Offering") of 2,400,000 Class A ordinary shares (the "Common Shares") at a public offering price of 4US$00 (the "Public Offering Price") for gross proceeds of US$9,600,000 (net of underwriting discounts and other offering expenses). The common stock has been approved for listing on the Nasdaq Capital Market and is expected to begin trading on January 26, 2024 under the symbol "HAO." The company provides one-stop online marketing solutions, especially in online short marketing, to help advertisers acquire and retain customers on popular Chinese platforms such as Toutiao, Douyin, WeChat, Sina Weibo, etc.
global news wire）
2. Major corporate events
1. Pharmaceutical digital operation: The Shanghai Biomedical Digital Operation Standard Innovation Consortium was established in Shanghai
On January 25, 2024, under the guidance of the Shanghai Municipal Administration for Market Regulation and the Pudong New Area Administration for Market Regulation, the "Inaugural Conference of the Shanghai Biomedical Digital Operation Standard Innovation Consortium" was held at the Shanghai Center, jointly sponsored by the Shanghai Pharmaceutical Industry Association, Shanghai Digital Industry Development ***, Xi'an Jiaotong-Liverpool University Industrialist College, Tencent Health, Yizhinuo Group and other units. Li Jing, Director of the Standard Innovation Division of the Shanghai Municipal Administration for Market Regulation, said that she hopes that the Shanghai Biopharmaceutical Digital Operation Standard Innovation Consortium can formulate innovative standards with world influence and continuously empower enterprises to upgrade and transform.
arterial net).2 AI Doctors: Sir Run Run Shaw Hospital of Zhejiang University has introduced AI doctor assistants to improve the efficiency of medical treatment
On January 15, 2024, it was learned that the Grand Canal Campus of Sir Run Run Shaw Hospital, affiliated to Zhejiang University School of Medicine, recently introduced AI doctor assistants during trial operation. Patients can use the WeChat mini-program "Shao Yi Smart Clinic" by scanning the display board in the hospital, complete the condition entry according to the page prompts, and generate pre-consultation medical records, so that doctors can understand the medical history in advance. This applet is an AI physician assistant based on a large language model. Ding Yong, director of the outpatient department of Sir Run Run Shaw Hospital of Zhejiang University, told reporters that AI doctor assistants can ask questions and guide patients by simulating the diagnosis and treatment thinking of clinicians, conduct multiple rounds of voice dialogues with one question and one answer, and quickly complete the collection of medical information such as patients' main symptoms, accompanying symptoms, diagnosis and treatment, and family history, and generate a complete pre-consultation case.
arterial net).3. Technological innovation
1 Surgical robot: Zhiyu Medical waterjet surgical robot completed the first clinical trial operation of waterjet robot in China
Recently, the waterjet surgical robot independently developed by Zhiyu Medical has successfully completed the first clinical trial operation of the waterjet robot in China. This is of great significance to rapidly improve the clinical application level of China's prostatic hyperplasia waterjet robot and break the monopoly of foreign brand markets. Combined with the characteristics of waterjet itself without heat, high efficiency and tissue selective cutting, the waterjet robotic surgery is precisely controlled by the computer, giving full play to the advantages of automatic operation of the robot, liberating the surgeon's hands, greatly reducing the doctor's repetitive operation, and protecting the patient's urinary control and sexual function to the greatest extent.
arterial net).2 Wearables: Studying wireless drug patches is expected to provide access to chronic diseases**
A team of scientists in the United States has created a new drug delivery system that can wirelessly receive commands from a smartphone or computer to schedule and trigger the release of a single microneedle. The thin, soft platform of patch-on-demand (SOP) resembles a plaster and is designed to improve the user's comfort and convenience, as wearability is a key factor for patients with chronic diseases. The technique, led by a research team led by Dr. Juan Song, professor of pharmacology at the University of North Carolina (UNC) School of Medicine, and Dr. Wubin Bai, assistant professor of applied physical sciences at the UCN College of Arts and Sciences, tested the use of patches in a mouse model to improve sleep using melatonin in microneedles. The study, published in the journal Nature Communications, opens the door to studying this wirelessly controlled patch on demand** for neurodegenerative diseases such as Alzheimer's disease.
healthtechwolrd）